Evidence map›Paper›PMID 42540566›Full record

ArticleAdvances in neurotoxicology2026

Nutraceuticals and obsessive-compulsive disorder therapy.

Amir Hossein Mohammadi, Negin Amin, Sayed Abolfazl Tavousi, Mahmood Khaksary Mahabady, Michael Aschner, Hamed Mirzaei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in neurotoxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amir Hossein MohammadiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Negin AminSchool of Health Science, College of Health, Massey University, Palmerston North, New Zealand.
Sayed Abolfazl TavousiStudent Research Committee, Kashan University of Medical Sciences, Kashan, Iran.
Mahmood Khaksary MahabadyAnatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, United States.
Hamed MirzaeiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.

Funding

Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
NIEHS NIH HHS R01 ES010563
6 · The paper itself

Abstract

Neurological disorders are a major public health concern. Notably, the rate of chronic neurological diseases is affected by lifestyle changes, leading to considerable health-care and economic burden worldwide. Considerable interest has emerged on functional foods due to their beneficial health efficacy. Thus, efforts have been made to extract different bioactive phytochemicals or compounds from therapeutic natural-based products, which has led to functional foods referred to as "vitafoods,""medifoods," "pharmafoods," or "medicinal foods." To overcome neurological illness such as obsessive-compulsive disorder (OCD), nutraceuticals have been applied as prophylactic options This review addresses nutraceutical intervention in the OCD treatment.

Indexed as

Food supplementsMental disorderNutraceuticalsObsessive-compulsive disorderProbiotic

Identifiers

PMID42540566
PMCPMC13426117

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.